Vycor Medical (VYCO) EBITDA Margin Growth (1y) (2011 - 2026)
Analysis
Vycor Medical (VYCO) EBITDA Margin Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | -497.00 |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 314.00 |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 124.00 |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 670.00 |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 546.00 |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 264.00 |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | -919.00 |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 595.00 |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 146.00 |
| 10 | Vycor Medical | 2.34 Mn | 2.18 Mn | 344,445.00 | -867.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -867.00 |
| Mar 31, 2026 | 1,292.00 |
| Dec 31, 2025 | -1,301.00 |
| Sep 30, 2025 | 1,523.00 |
| Jun 30, 2025 | 632.00 |
| Mar 31, 2025 | -11.00 |
| Dec 31, 2024 | 2,503.00 |
| Sep 30, 2024 | -73.00 |
| Jun 30, 2024 | -1,601.00 |
| Mar 31, 2024 | -1,203.00 |
| Dec 31, 2023 | 1,284.00 |
| Sep 30, 2023 | 2,015.00 |
| Jun 30, 2023 | 4,267.00 |
| Mar 31, 2023 | 2,605.00 |
| Dec 31, 2022 | 2,637.00 |
| Sep 30, 2022 | -179.00 |
| Jun 30, 2022 | -2,746.00 |
| Mar 31, 2022 | 5,308.00 |
| Dec 31, 2021 | 1.00 |
| Sep 30, 2021 | 4,817.00 |